에 대한 최신 뉴스 Immutep (NASDAQ:IMMP) 주식

Immutep

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Immutep Limited - American Depositary Shares

Immutep Ltd

Press Releases

Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC Class II

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761

Patient Enrolment Completed for INSIGHT-003

Patient Enrolment Completed for EFTISARC-NEO Phase II Trial

Immutep Quarterly Activities Report Q2 FY25

Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025

First Patient Dosed in Immutep's TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer

Immutep to Participate in Upcoming Investor Conferences

Immutep Quarterly Activities Report Q3 FY25

Immutep's Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1

IMMP

Abeona Therapeutics

Absci

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

aTyr Pharma

Aura Biosciences

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Emergent BioSolutions

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Oruka Therapeutics

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Rezolute

Solid Biosciences

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

2seventy bio

Vanda Pharmaceuticals Inc. - Common Stock

Comments

Immutep

뉴스

에 대한 최신 뉴스 Immutep (NASDAQ:IMMP) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌